RECRUITING

Developing Resilience and Anxiety Management Through the Arts

Conditions

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The Developing Resilience and Anxiety Management Through the Arts (DRAMA) Study examines the degree to which the arts can help to address stress, anxiety, and sad mood in children and adolescents. The researchers will pair theatrical improvisation exercises with cognitive-behavioral therapy (CBT) techniques versus improvisation exercises alone versus a social craft group on reducing elevated levels of anxiety and depression.

Official Title

Developing Resilience and Anxiety Management Through the Arts (DRAMA) 2

Quick Facts

Study Start:2025-04-15

Study Completion:2027-07-01

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:RECRUITING

Study ID

NCT07033052

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:8 Years to 17 Years

Sexes Eligible for Study:ALL

Accepts Healthy Volunteers:No

Standard Ages:CHILD

Inclusion Criteria	Exclusion Criteria
* Between 8 and 17 years of age * Individuals must have parental/guardian consent * Elevated levels of anxiety or depression based on 1. Screen for Child Anxiety Related Disorders (SCARED) score of 15 or higher, or; 2. Revised Children's Anxiety and Depression Scale (RCADS) Depression T score of 65 or higher, or; 3. Kiddie Schedule for Affective Disorders and Schizophrenia (K-SADS) clinician severity rating of 3 on any anxiety disorder or on a mood-related disorder	* Diagnosed with Conduct Disorder or with behavioral symptoms that would make it difficult for the child/adolescent to participate in the group or comply with directions given by the group leader (such as difficulty following instructions, difficulty staying in one's seat, defiance of adults, harming animals or people, threatening others, getting into physical fights, hyperactivity, impulsivity, difficulty waiting for one's turn, etc.) * Autism or developmental delays * Psychotic symptoms or active suicidality * Active Eating Disorders that raise concerns about morbidity and therefore need to be addressed in an intervention and actively monitored * Unsteady dosage or recently or impending changes to psychotropic medication(s) * Non-English-speaking individuals * Wards of the State

Inclusion Criteria

Exclusion Criteria

* Between 8 and 17 years of age
* Individuals must have parental/guardian consent
* Elevated levels of anxiety or depression based on
1. Screen for Child Anxiety Related Disorders (SCARED) score of 15 or higher, or;
2. Revised Children's Anxiety and Depression Scale (RCADS) Depression T score of 65 or higher, or;
3. Kiddie Schedule for Affective Disorders and Schizophrenia (K-SADS) clinician severity rating of 3 on any anxiety disorder or on a mood-related disorder

* Diagnosed with Conduct Disorder or with behavioral symptoms that would make it difficult for the child/adolescent to participate in the group or comply with directions given by the group leader (such as difficulty following instructions, difficulty staying in one's seat, defiance of adults, harming animals or people, threatening others, getting into physical fights, hyperactivity, impulsivity, difficulty waiting for one's turn, etc.)
* Autism or developmental delays
* Psychotic symptoms or active suicidality
* Active Eating Disorders that raise concerns about morbidity and therefore need to be addressed in an intervention and actively monitored
* Unsteady dosage or recently or impending changes to psychotropic medication(s)
* Non-English-speaking individuals
* Wards of the State

Contacts and Locations

Study Contact

Amy Przeworski, PhD

CONTACT

216-368-5021

axp335@case.edu

Principal Investigator

Amy Przeworski, PhD

PRINCIPAL_INVESTIGATOR

Case Western Reserve University

Study Locations (Sites)

Case Western Reserve University

Cleveland, Ohio, 44106

United States

Collaborators and Investigators

Sponsor: Case Western Reserve University

Amy Przeworski, PhD, PRINCIPAL_INVESTIGATOR, Case Western Reserve University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-04-15

Study Completion Date2027-07-01

Study Record Updates

Study Start Date2025-04-15

Study Completion Date2027-07-01

Terms related to this study

Additional Relevant MeSH Terms

Anxiety
Depression
Mood